Pharmacists Improve Care of Diabetics While Cutting Costs

The role of pharmacists hasn’t received much attention in the debate on the cost of health care. But national and regional studies show that when pharmacists directly participate in patient care, they significantly reduce therapy costs and improve outcomes. A study on diabetic patients by the University at Buffalo School of Pharmacy and Pharmaceutical Sciences identified cost savings with improvements in a key indicator of glucose control in diabetes patients, the hemoglobin A1C measurement. The A1C provides a three-month average of the amount of excess glucose in the blood. Higher A1Cs indicate that a patient is at higher risk for developing long-term complications linked to diabetes, such as kidney disease or vision problems……..

Rapid-acting insulin analogues

Due to a lack of suitable studies, it remains unclear whether children and adolescents with type 1 diabetes benefit more or less from long-term therapy with rapid-acting insulin analogues than with short-acting human insulin. Certainly, there is no proof of additional benefit from the available results from clinical trials of maximum one year duration. This applies both in the comparison with human insulin and in the comparison between analogues only. This is the conclusion of the final report of the Institute for Quality and Efficiency in Health Care (IQWiG) published on 16 November 2009……..

An Old Dawg Can Learn New Tricks!

In an interview with Diabetes Forecast – the consumer magazine of the American Diabetes Association – Randy Jackson reveals his type 2 diabetes story, the hurdles and the path to therapy. This year, Randy Jackson celebrates 10 years of type 2 diabetes: Jackson, who was diagnosed with type 2 diabetes in 1999, was shocked when he learned that he had a chronic disease. „They were sneaky symptoms,“ he says. „Of course, I didn’t take into consideration that a history of type 2 diabetes ran in my family, because you always believe that happens to somebody else, not you.“…….

Biomarkers For Diabetic Kidney Failure

Pooled DNA technique identifies variances that could indicate susceptibility to end-stage renal disease. PHOENIX, Ariz. — Dec. 16, 2009 — Scientists using a DNA analysis tool developed by the Translational Genomics Research Institute (TGen) and UCLA have identified genetic markers that could help treat chronic kidney disease among diabetics……..

Reducing sugar and increasing fiber intake

Reducing sugar intake by the equivalent of one can of soda per day and increasing fiber intake by the amount equivalent to one half cup of beans per day appears to improve risk factors linked to type 2 diabetes in Latino adolescents, as per a report in the recent issue of Archives of Pediatrics and Adolescent Medicine, one of the JAMA/Archives journals……..

Discount Pharmacy: Can They Really Save You Money?

Here is a question that can fetch you several ontrasting replies; while some may respond cheerily, an equally striking number may respond rather grimly. The reason being that experiences vary and so do the lessons that we learn. If someone has been able to strike an exciting deal at a discount pharmacy, chances are he’ll seek the services again. So, the question here is: are discount pharmacies really beneficial? Do they actually help save money? The answer is influenced by how and where you search for a discount pharmacy. To start with, you must find a reputable and licensed online drug store that is also of a kind that you feel comfortable recommending to your family or friends. …….

Treating gum disease in diabetics

A new report shows that treating gum disease in patients who have diabetes with procedures such as cleanings and periodontal scaling is associated with 10 to 12 percent lower medical costs per month. The findings are encouraging but the study was not designed to firmly establish cause and effect, said George Taylor, University of Michigan associate professor of dentistry, who also has an appointment in epidemiology in the U-M School of Public Health. Taylor led the research project to investigate whether routine, non-surgical therapy for gum disease is associated with lower medical care costs for people with diabetes……..

Sitagliptin could trigger pancreatitis

A drug widely used to treat Type 2 diabetes may have unintended effects on the pancreas that could lead to a form of low-grade pancreatitis in some patients and a greater risk of pancreas cancer in long-term users, UCLA scientists have found. As per a research findings reported in the online edition of the journal Diabetes, scientists from the Larry L. Hillblom Islet Research Center at UCLA observed that sitagliptin, sold in pill form as Januvia, caused abnormalities in the pancreas that are recognized as risk factors for pancreatitis and, with time, pancreas cancer in humans. Januvia is marketed by Merck and Co. Inc. Sitagliptin is a member of a new class of drugs that enhance the actions of the gut hormone known as glucagon-like peptide 1 (GLP-1), which has been shown to be effective in lowering blood sugar in people with Type 2 diabetes. The study is available at http://diabetes.diabetesjournals.org/cgi/content/abstract/db09-0058v1……..